The stability of prostaglandin E1 ethylester

Chinese Pharmaceutical Journal

Volumn 50, Issue 2, 1998, Pages 97-105

  Lin, Lun Huei ^a   Ho, Hsiu O ^a   Chen, Kuo Tung ^a   Chiang, Han Sun ^a   Wong, Patrick Y K ^b   Sheu, Ming Thau ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Degradation pathway; Prostaglandin E1 ethylester; Stability

Indexed keywords

11,15 DIHYDROXY 9 OXOPROST 13 EN 1 OIC ETHYL ESTER; PROSTAGLANDIN E1; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E1 ETHYL ESTER; UNCLASSIFIED DRUG;

ARTERY OCCLUSION; ARTICLE; DRUG DEGRADATION; DRUG DIFFUSION; DRUG STABILITY; LIPOPHILICITY; PROSTAGLANDIN METABOLISM;

EID: 0031829474     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wendel, H.; Braun, F. J. Transdermal Prostaglandin Composition. U.S. Patent 5,380,760, 1995.
2. 1 Derivatives as Pharmaceutically Active Agents, and Pharmaceutical Compositions Containing These Compounds, Especially for Transcutaneous Administration. U.S. Patent 5, 219,885, 1993.
3. 1 in Solution. J. Chromatogr. 1991, 555, 73-80.
4. 2. J. Pharm. Sci. 1973, 62, 576-580.
5. 2) under Strongly Acidic and Basic Conditions. J. Pharm. Sci. 1977, 66, 1590-1595.
6. Andersen, N. H. Dehydration of Prostaglandins: Study by Spectroscopic Method. J. Lipid Research. 1969, 10, 320-325.
7. 1 in a Lipid Emulsion. Pharm. Res. 1989, 6, 210-215.
8. 3 in Frog Tissue. J. Chromatogra. 1987, 394, 353-362.
9. 1 and Its Ethyl Ester. J. Controlled Release, in press 1998.